Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ZKSCAN4 antibody

ZKSCAN4 Reactivity: Human, Mouse IHC, IF Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7076265
  • Target See all ZKSCAN4 Antibodies
    ZKSCAN4 (Zinc Finger Protein 307 (ZKSCAN4))
    Reactivity
    • 48
    • 19
    • 14
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    Human, Mouse
    Host
    • 43
    • 5
    Rabbit
    Clonality
    • 44
    • 3
    Polyclonal
    Conjugate
    • 21
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This ZKSCAN4 antibody is un-conjugated
    Application
    • 29
    • 20
    • 11
    • 11
    • 3
    • 1
    • 1
    Immunohistochemistry (IHC), Immunofluorescence (IF)
    Cross-Reactivity
    Mouse
    Purification
    Affinity purification
    Immunogen
    Recombinant protein corresponding to Human ZNF307
  • Application Notes
    IHC/IF (H,M) 1:400-1:1600
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS, pH 7.4, 0.02 % sodium azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
  • Target
    ZKSCAN4 (Zinc Finger Protein 307 (ZKSCAN4))
    Alternative Name
    ZNF307 (ZKSCAN4 Products)
    Synonyms
    ZKSCAN4 antibody, ZNF307 antibody, P1P373C6 antibody, ZNF427 antibody, ZSCAN36 antibody, p373c6.1 antibody, Zfp307 antibody, Znf307 antibody, AI841875 antibody, Gm11272 antibody, OTTMUSG00000000421 antibody, zinc finger with KRAB and SCAN domains 4 antibody, ZKSCAN4 antibody, Zkscan4 antibody
    Background
    ZNF307 contains 1 SCAN box domain, 1 KRAB domain and 7 C2H2-type zinc fingers. It belongs to the Krueppel C2H2-type zinc-finger protein family and may be involved in transcriptional regulation.
    Gene ID
    387032
    NCBI Accession
    NP_061983
    UniProt
    Q969J2
You are here: